Barchart.com
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Tevogen Bio Holdings Inc WT (TVGNW)

Tevogen Bio Holdings Inc WT (TVGNW)
0.0445 +0.0014 (+3.25%) 04/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
News & Headlines for Mon, Apr 14th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ’s Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald GlobeNewswire - Mon Apr 14, 12:53PM CDT

TVGNW : 0.0445 (+3.25%)
TVGN : 1.0500 (-2.78%)
Tevogen Announces Tevogen Generics, a New Effort in Support of President Trump’s Initiative to Encourage Pharmaceutical Manufacturing in United States GlobeNewswire - Wed Apr 9, 1:45PM CDT

TVGNW : 0.0445 (+3.25%)
TVGN : 1.0500 (-2.78%)
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs GlobeNewswire - Tue Apr 8, 4:53PM CDT

TVGNW : 0.0445 (+3.25%)
TVGN : 1.0500 (-2.78%)
Tevogen Bio Highlights Most Recent Insider Ownership of 74%; Management Maintains Conviction in the Company’s Mission GlobeNewswire - Mon Apr 7, 2:58PM CDT

TVGNW : 0.0445 (+3.25%)
TVGN : 1.0500 (-2.78%)
Tevogen Bio CEO Named to NJBIZ 2025 Health Care Power List as Company Advances Commercialization; Reaffirms Timeframe on Previously Announced Forecast GlobeNewswire - Wed Mar 26, 2:12PM CDT

TVGNW : 0.0445 (+3.25%)
TVGN : 1.0500 (-2.78%)
Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan GlobeNewswire - Tue Mar 25, 12:11PM CDT

TVGNW : 0.0445 (+3.25%)
TVGN : 1.0500 (-2.78%)
Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent with the USPTO GlobeNewswire - Mon Mar 10, 11:40AM CDT

TVGNW : 0.0445 (+3.25%)
TVGN : 1.0500 (-2.78%)
Tevogen Bio’s CIO & Head of Tevogen.AI, Mittul Mehta, Featured Speaker at Proskauer’s AI Discussion Panel GlobeNewswire - Fri Mar 7, 3:09PM CST

TVGNW : 0.0445 (+3.25%)
TVGN : 1.0500 (-2.78%)
Tevogen Bio to Receive $8 Million of Non-Dilutive Grant Funding, Reiterates Efficient Operations GlobeNewswire - Mon Mar 3, 11:52AM CST

TVGNW : 0.0445 (+3.25%)
TVGN : 1.0500 (-2.78%)
Tevogen Bio Founder and CEO Dr. Ryan Saadi Named to 2025 NJBIZ Power 100, Celebrating Innovation and Leadership in Accessible T Cell Therapy GlobeNewswire - Fri Feb 28, 12:17PM CST

TVGNW : 0.0445 (+3.25%)
TVGN : 1.0500 (-2.78%)

Barchart Exclusives

These 2 Dividend Aristocrats Are Top Stocks to Buy in Times of Uncertainty Barchart - 1 hour ago
These companies offer consistent dividend growth and a strong industry presence. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
UTC
Reserve Your Spot